Surgical Management of Breast Cancer during COVID-19 Pandemic
DOI:
https://doi.org/10.21649/akemu.v30i2.5560Keywords:
American Society of Anesthesiologists (ASA) grade, Body mass index (BMI), Coronavirus Disease 19(COVID-19), TNM classification (tumor size, lymph node, and metastasis)Abstract
Background: Breast cancer is the most common cancer in women worldwide, including Pakistan. Pakistan has the highest prevalence of breast cancer in Asia, according to reports.
Objective: To compare the management of breast cancer patients in pre and post COVID-19 timeline, and to observe for any stage progression in both groups.
Methods: In this retrospective cohort study, conducted at West Surgical Ward, Mayo Hospital Lahore, from July 2019 to Dec 2020, adult female patients aged 18 years or older with a history of breast cancer surgery or who visited the breast clinic with the a diagnosis of breast cancer were enrolled. We divided them into pre and post COVID-19 subgroups assessed in nine months each. Variables including ASA grade, BMI, referral, size of tumor, number of lymph nodes removed, surgical procedure performed including axillary surgery, TNM stage, type of cancer. extracted from patient charts retrospectively. Univariate regression analysis performed for the progression of the stage. P-value ≤0.05 considered significant.
Results: Two hundred and sixty-two (n=262) patients presented during the pre-COVID-19 time (Group A) and one hundred seventy-one (n=171) presented in post-COVID-19 times (Group B). All were female patients, with a mean age of 46.6±10.1 year's in-group A and 45.6±11.8 years in-group B. Significantly, referral patients attendance reduced in group B (10.5%) as compared to group A (70.6%). Metastatic disease (stage 4) also seen in higher number in post COVID-19 (26.2% vs. 35%). Stage progression was real in post Covid-19 group (24.6% vs. 6.5%). Results showed waiting time before visiting the breast clinic (p<0.001) and before radiotherapy (p=0.04) were contributing factors to the progression of the disease.
Conclusion: Stage progression is real in the post-COVID-19 subgroup. Waiting time before visiting the breast clinic and before radiotherapy were main factors for the progression of the disease.
References
Menhas R, Shumaila UM. Breast cancer among Pakistani women. Iran. J. Public Health. 2015 ;44(4):586.
Soomro R. Is breast cancer awareness campaign effective in Pakistan? J Pak Med Assoc. 2017; 67(1): 1070-3.
Shamsi U, Khan S, Azam I, Usman S, Maqbool A, Gill T, et al. Patient delay in breast cancer diagnosis in two hospitals in Karachi, Pakistan: Preventive and life-saving measures needed. J Glob Oncol. 2020; 6(1) :873-83.
Coleman C. Early Detection and Screening for Breast Cancer. Semin Oncol Nurs.2017; 33(1) :141-155.
Veronesi P, Corso G. Impact of COVID-19 pandemic on clinical and surgical breast cancer management. E Clinical Medicine. 2020:26(1); 1-2.
Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020; 10(1) :783-91.
Qazi SH, Saleem A, Pirzada AN, Hamid LR, Dogar SA, Das JK. Challenges to delivering pediatric surgery services in the midst of COVID 19 crisis: experience from a tertiary care hospital of Pakistan. Pediatr Surg Int. 2020; 36(1) :1-7.
Brown JM, Wasson MC, Marcato P. Triple-Negative Breast Cancer and the COVID-19 Pandemic: Clinical Management Perspectives and Potential Consequences of Infection. Cancers. 2021; 13(1):296.
Li J, Wang H, Geng C, Liu Z, Lin Y, Nie J et al. Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020. E Clinical Medicine. 2020; 26(1) :100503.
Dietz JR, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, Burstein HJ et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat. 2020;181(3):487-497..
Richards M, Anderson M, Carter P, Ebert BL, Mossialos E. The impact of the COVID-19 pandemic on cancer care. Nat Cancer. 2020;1(6):565-7.
De Guzman R, Malik M. Dual challenge of cancer and COVID-19: impact on health care and socioeconomic systems in Asia Pacific. J Glob Oncol. 2020; 6(1) :906-12.
COVID-19: Pakistani hospitals suspend outpatient clinics [internet]. 2021 [cited 1 May 2021]. Available from: https://www.aa.com.tr/en/asia-pacific/covid-19pakistani-hospitals-suspend-outpatient-clinics/1778600
Filipe MD, van Deukeren D, Kip M, Doeksen A, Pronk A, Verheijen PM, et al. Effect of the COVID-19 pandemic on surgical breast cancer care in the Netherlands: a multicenter retrospective cohort study. Clin. breast cancer. 2020;20(6):454-61.
Gathani T, Clayton G, MacInnes E, Horgan K. The COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020. Br. J. Cancer. 2021; 124(1):710-2.
Nyasulu J, Pandya H. The effects of coronavirus disease 2019 pandemic on the South African health system: A call to maintain essential health services. Afr J Prim Health Care Fam Med. 2020;2(1):e1-e5.
Burki TK. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol. 2020; 21(1):629-30.
COVID-19: Pakistani hospitals suspend outpatient clinics [internet]. 2021 [cited 1 May 2021]. Available from: https://www.aa.com.tr/en/asia-pacific/covid-19pakistani-hospitals-suspend-outpatient-clinics/1778600.
Kumar D, Dey T. Treatment delays in oncology patients during COVID-19 pandemic: A perspective. J Glob Health. 2020;10(1):010367.
Sud A, Torr B, Jones ME, Broggio J, Scott S, Loveday C et al. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 2020;21(8):1035-1044.
Alaidy Z, Mohamed A, Euhus D. Breast cancer progression when definitive surgery is delayed. Breast J. 2021;27(4):307-313.
Chang SB, Savitz AC, Vuong B, Tang A, Mentakis M, Miller AM, et al. Abstract SS2-06: Characterization of breast cancer management during the COVID 19 pandemic in a large integrated healthcare delivery system: Stage at diagnosis and timing/modality of first treatment. Cancer Res. 2021;81(4_Supplement): SS2-06.
Park KU, Gregory M, Bazan J, Lustberg M, Rosenberg S, Blinder V et al. Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic. Breast Cancer Res Treat. 2021;188(1):249-258.
American Society of Plastic Surgeons. ASPS’ statement on breast reconstruction in the face of COVID-19 pandemic.[Internet]. 2020. [cited 2023 Dec 3]. Available from: https://www.plasticsurgery.org/documents/medical-professionals/COVID19-Breast-Reconstruction-Statement.pdf
İlgün AS, Özmen V. The impact of the COVID-19 pandemic on breast cancer patients. Eur J Breast Health. 2021;18(1):85-90.
Vijaykumar DK, Pavithran K, Soman S, Jayamohanan H, Dharmarajan J. Impact of COVID-19 on the Diagnosis and Surgical Care of Patients with Breast Cancer—a Retrospective Observational Cohort Study from Kerala, South India. Indian J Surg Oncol. 2023;14(1):6-10.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Annals of King Edward Medical University
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments publications@kemu.edu.pk